Anti-Human CD163 receptor Therapeutic Antibody scFv Fragment (TBI 304H)

Ask supplier a question | View on supplier's website

TBI 304H is a humanized monoclonal antibody designed to target the CD163 receptor pathway on hematopoietic progenitor cells as a potential treatment of anemia.

Supplier	Creative Biolabs
Product #	TAB-1610CL-S(P)
Pricing	Inquiry
Type	Humanized antibody
Host	Human
Target	CD163 receptor

Feedback